Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Other Working Capital Changes (2023 - 2025)

Historic Other Working Capital Changes for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $1.7 million.

  • Tonix Pharmaceuticals Holding's Other Working Capital Changes rose 39149.56% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$784000.0, marking a year-over-year decrease of 17186.07%. This contributed to the annual value of -$3.6 million for FY2024, which is 12968.85% down from last year.
  • Tonix Pharmaceuticals Holding's Other Working Capital Changes amounted to $1.7 million in Q3 2025, which was up 39149.56% from -$134000.0 recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Other Working Capital Changes ranged from a high of $1.8 million in Q4 2023 and a low of -$3.1 million during Q3 2023
  • In the last 3 years, Tonix Pharmaceuticals Holding's Other Working Capital Changes had a median value of $341000.0 in 2024 and averaged -$275181.8.
  • In the last 5 years, Tonix Pharmaceuticals Holding's Other Working Capital Changes crashed by 26712.1% in 2024 and then soared by 39149.56% in 2025.
  • Tonix Pharmaceuticals Holding's Other Working Capital Changes (Quarter) stood at $1.8 million in 2023, then crashed by 267.12% to -$2.9 million in 2024, then skyrocketed by 156.95% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, -$134000.0 for Q2 2025, and $617000.0 during Q1 2025.